Robert K. Hills

1985–2025 年に発表

別表記
Robert K Hills
102
論文数
23,754
被引用数
78
h 指数
100
i10 指数

被引用数

Robert K. Hills の年別被引用数1958 年: 被引用 1 件1986 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 2 件1993 年: 被引用 1 件1995 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 2 件2000 年: 被引用 1 件2001 年: 被引用 12 件2002 年: 被引用 12 件2003 年: 被引用 9 件2004 年: 被引用 15 件2005 年: 被引用 21 件2006 年: 被引用 44 件2007 年: 被引用 63 件2008 年: 被引用 76 件2009 年: 被引用 107 件2010 年: 被引用 152 件2011 年: 被引用 171 件2012 年: 被引用 186 件2013 年: 被引用 205 件2014 年: 被引用 227 件2015 年: 被引用 224 件2016 年: 被引用 293 件2017 年: 被引用 257 件2018 年: 被引用 249 件2019 年: 被引用 926 件2020 年: 被引用 891 件2021 年: 被引用 877 件2022 年: 被引用 572 件2023 年: 被引用 503 件2024 年: 被引用 805 件2025 年: 被引用 370 件2026 年: 被引用 3 件1959〜1985 年は被引用が無いため表示していません1987〜1990 年は被引用が無いため表示していません1994 年は被引用が無いため表示していません1996〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,082 件、この内訳の 22.6%イギリス: 引用元論文 802 件、この内訳の 8.7%ドイツ: 引用元論文 756 件、この内訳の 8.2%中国: 引用元論文 606 件、この内訳の 6.6%イタリア: 引用元論文 568 件、この内訳の 6.2%フランス: 引用元論文 463 件、この内訳の 5%オランダ: 引用元論文 354 件、この内訳の 3.8%スペイン: 引用元論文 316 件、この内訳の 3.4%カナダ: 引用元論文 279 件、この内訳の 3%オーストラリア: 引用元論文 274 件、この内訳の 3%スイス: 引用元論文 207 件、この内訳の 2.3%日本: 引用元論文 187 件、この内訳の 2%
0%22.6%その他 25.2%

分野

  • Medicine75.8%
  • Biochemistry, Genetics and Molecular Biology17.7%
  • Immunology and Microbiology3.6%
  • Neuroscience0.9%
  • Computer Science0.5%
  • Engineering0.3%
  • その他1.2%

トピック

  • Acute Myeloid Leukemia Research16.6%
  • Acute Lymphoblastic Leukemia research4.6%
  • Hematopoietic Stem Cell Transplantation4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.1%
  • Chronic Myeloid Leukemia Treatments3%
  • Histone Deacetylase Inhibitors Research2.7%
  • その他66%

共著者

全論文

検索で開く
  1. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2018 被引用: 1,029

  2. Assessment of Minimal Residual Disease in Standard-Risk AML

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 836

  3. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain - The Lancet Oncology 2022 被引用: 299

  4. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

    著者: , , , , , , , , - Blood 2010 被引用: 1,951

  5. openalex_id:w4226348827

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, R. Jakesz, Christian Fesl, Olivia Pagani, Richard D. Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy S. Albain, Stewart Anderson, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain 被引用: 223

  6. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles E. Geyer, M. Spielmann, Pinuccia Valagussa, Kathy S. Albain, Stewart Anderson, R. Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Bidwell Goetz, Pam Goodwin, Pat Halpin-Murphy, Daniel Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori J. Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Tanja Španić, Joseph A. Sparano, Guenther G. Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Timothy J. Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I. Pritchard ほか 1 名 - The Lancet Oncology 2021 被引用: 348

  7. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren ほか 136 名 - The Lancet 2023 被引用: 189

  8. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber ほか 67 名 - The Lancet 2019 被引用: 394

  9. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Amanda Kerr, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Mariko Nakahara, Simon Read, Hannah Taylor, John Ferguson, H Scheurlen, Stefano Zurrida, Viviana Galimberti, James N. Ingle, Pinuccia Valagussa, Umberto Veronesi, Stewart Anderson, Gong Tang, Bernard Fisher, Sophie D. Fosså, Kristin V. Reinertsen, Herman Høst, Hyman B. Muss, Kaija Holli, Kathy S. Albain, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, José Á. García-Sáenz, Rich Gelber, Michael Gnant, Matthew P. Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Stuart McIntosh, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Martine Piccart, Lori J. Pierce, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Roberto Salgado, Dennis J. Slamon, Tanja Španić ほか 14 名 - The Lancet 2023 被引用: 151

  10. Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials

    著者: , , , , , , , , , , , , , , - The Lancet Oncology 2014 被引用: 698

  11. Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tony Johnson, Peter Bentham, Patrick Phillips - New England Journal of Medicine 2012 被引用: 766

  12. Unified classification and risk-stratification in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 175

  13. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , - The Lancet Oncology 2015 被引用: 543

  14. Molecular MRD status and outcome after transplantation in NPM1-mutated AML

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anjum Khan, Rahuman Salim, Charles Craddock, Ruth Spearing, Amanda Gilkes, Rosemary E. Gale, Alan K. Burnett, Nigel H. Russell, David Grimwade - Blood 2020 被引用: 166

  15. Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

    著者: , , , , , - Blood 2012 被引用: 419

  16. Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 200

  17. EZH2 mutations are frequent and represent an early event in follicular lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Kohlmann, Torsten Haferlach, Randy D. Gascoyne, Jude Fitzgibbon - Blood 2013 被引用: 323

  18. Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

    著者: , , , , , , , , - Journal of Clinical Oncology 2013 被引用: 415

  19. Association between premature mortality and hypopituitarism

    著者: , , , , , , , - The Lancet 2001 被引用: 1,009

  20. Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling

    著者: , , , , , , , , , , - Blood 2013 被引用: 230

  21. Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 164

  22. A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

    著者: , , , , , , , , , , , , - Blood 2015 被引用: 295

  23. Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    著者: , , , , , , , , , - Journal of Clinical Oncology 2010 被引用: 652

  24. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

    著者: , , , , , , - Blood 2007 被引用: 744